Comar's Commitment to Regulatory Excellence
Comar is a recognized leader in healthcare packaging, consistently setting high standards in regulatory compliance and patient safety. The company's recent achievement of CE certification under the EU Medical Device Regulation (EU MDR 2017/745) reinforces its dedication not only to regulatory excellence but also to enhancing the success of its customers in European markets. This significant milestone reflects Comar's strategic vision and commitment to providing innovative solutions that meet strict regulatory requirements.
Advanced UDI Labeling Capabilities
In tandem with its CE certification, Comar has made a considerable investment in advanced Unique Device Identification (UDI) labeling capabilities. This positions the company as a leader in compliance within the medical device sector. The updated EU MDR introduces rigorous requirements for product traceability, mandating visible, clear, and permanent CE markings and UDI labels on all devices and associated packaging. Comar has meticulously developed robust in-house systems, ensuring that every product satisfies UDI requirements for both Device Identifier (UDI-DI) and Production Identifier (UDI-PI), readable by both humans and machines.
Ensuring Safety and Ease of Compliance
Comar's UDI labeling process is designed to provide clear identification and enable efficient traceability, thereby facilitating swift recalls should they become necessary. As Sonia Hardikar, Vice President of Quality and Regulatory Affairs at Comar states, "It's all about protecting patients while simplifying compliance for our clients." This proactive approach not only prioritizes safety but also eases the regulatory burden on clients preparing to enter or expand in the European market.
Comar's Capabilities as a Contract Manufacturer
As a contract manufacturer, Comar possesses the necessary tools and expertise to assign, generate, and apply CE labels and UDI codes for a diverse range of medical devices. This includes essential products like oral syringes, AccuCup® dosage cups, dropper assemblies, and press-in bottle adapters. By leveraging its extensive experience and dedicated resources, Comar stands ready to effectively support its clients in navigating the complexities of medical device regulations.
Comprehensive Regulatory Support for Clients
Beyond simply producing its own products, Comar is committed to providing regulatory and labeling assistance for clients shipping devices into the European Union. Cari Smith, Director of Quality Systems and Regulatory Affairs, emphasizes the company's role: "We actively help our clients navigate EU MDR requirements." With a talented regulatory and labeling team, Comar offers practical solutions that facilitate client readiness for product importation into the EU market.
Confidence in European Markets
Comar's proactive compliance efforts have secured early CE certification under the EU MDR, ensuring uninterrupted access to European markets. This certification delivers peace of mind to customers searching for a trustworthy partner in an ever-evolving regulatory landscape. As Hardikar notes, "Our investment enhances our value to customers preparing for EU MDR," highlighting the company's commitment to facilitating smooth operations for its partners.
About Comar
Comar, headquartered in Voorhees, NJ, operates 11 strategically located manufacturing facilities. The company excels in various plastic molding technologies, including injection molding, blow molding, and extrusion. With over 75 years of experience, Comar has successfully partnered with clients to transform innovative packaging and medical solutions from concept to reality, creating products that significantly impact the world. Comar has also been recognized with a Silver Medal, ranking within the top 15% of companies evaluated by EcoVadis, underlining its commitment to environmental, social, and ethical responsibility. Morgan Stanley Capital Partners holds a majority stake in the company.
Frequently Asked Questions
What is Comar's recent achievement regarding EU regulations?
Comar has achieved CE certification under the EU Medical Device Regulation (EU MDR 2017/745), reinforcing its commitment to compliance and patient safety.
What are UDI labeling capabilities?
UDI labeling capabilities ensure that each medical device is identified clearly, traceable, and compliant with regulatory standards, enhancing safety and recall processes.
What products does Comar manufacture under this compliance?
Comar produces a variety of medical devices, including oral syringes, AccuCup® dosage cups, dropper assemblies, and press-in bottle adapters, all of which meet CE and UDI requirements.
How does Comar support its clients with EU MDR navigation?
Comar provides regulatory and labeling support to help clients understand and meet EU MDR requirements, facilitating smooth market entry and compliance.
What is the significance of Comar's early CE certification?
Early CE certification ensures uninterrupted access to European markets and builds customer trust, indicating Comar as a reliable partner in the medical device landscape.
